Showing posts with label M2012. Show all posts
Showing posts with label M2012. Show all posts

Monday, May 7, 2012

[VIDEO] McGowan and Pickett Talk the Rectal Microbicide Walk at Microbicides 2012

Rectal microbicides were ALL OVER the Microbicides 2012 conference...


Chatting up rectal microbicide research and advocacy activities and issues at the recent Microbicides 2012 conference (held in Sydney this past April) were Dr. Ian McGowan, co-principal investigator of the Microbicide Trials Network (and IRMA Scientific Co-Chair) and IRMA Chair Jim Pickett.

Have a look/listen to their discussion with reporters.



 

*Check out pics from the Microbicides 2012 conference on IRMA's Facebook page.

-------------------


*Join IRMA's robust, highly-active. moderated, global listserv addressing rectal microbicide research and advocacy as well as other interesting new HIV prevention technologies by contacting us. Joining our listserv automatically makes you a member of IRMA - a network of more than 1,100 advocates, scientists, policy makers and funders from all over the world.

*Also, please note that shared news items from other sources posted on this blog do not necessarily mean IRMA has taken any position on the article's content.

-------------------

 


Tuesday, April 17, 2012

Sydney Microbicides 2012 Media Coverage : New Information on Lubricants and Anal Health

via Citizen News, by Bobby Ramakant

For how long will anal health and hygiene be neglected?


“It is high time that anal health [and hygiene] comes out of the closet” said Dr Ross Cranston, Assistant Professor, University of Pittsburgh, USA. Dr Cranston was referring to the multitude of anal health complications people practicing receptive anal intercourse are likely to be dealing with in their lives and very little quality care and products that exist to relieve them. Dr Cranston was speaking at the International Microbicides Conference (M2012) in Sydney, Australia. According to the UNAIDS, United Nations joint programme on HIV/AIDS, men-who-have-sex-with-men (MSM) are at a high risk of HIV around the world.
Many countries such as those in Africa who had earlier reported no significant HIV rates in people with same sex behaviour, have reported alarming HIV rates in recent past.

Although ‘anal’ and ‘rectal’ words are used as synonyms, but they aren’t same – and rather refer to different parts biologically. Anal canal is distinct from rectal canal with a unique set of diagnosis. Rectal canal is made up of columnar epithelial cells and anal canal is made up of stratified epithelial cells. Anal canal is also a high pressure environment with about 77 mmHg pressure when sphincters are resting and 180 mmHg pressure when sphincters constrict. In contrast, pressure in human vagina is 0 mmHg in resting phase.

Anal canal is very sensitive to hot, cold, wet, dry, light touch, pin prick, distension, pleasure or pain, however rectal canal is only sensitive to distension, pleasure or pain.
The incidence of adverse events in rectal microbicides studies is quite high with 11% symptoms and signs of anal adverse events in anal canal and 13% in rectal canal. These adverse events include prolapsing haemorrhoids (piles), anal fissure, anal fistula, anal abscess, anal warts, anal or rectal canal cancers, fungal infections, herpes simplex virus (HSV) infection, or sexually transmitted infections (STIs).

The need for right awareness in healthcare providers and their appropriate training is acute as often anal adverse events are misdiagnosed or ill-treated.

The awareness level in people (men and women) who reported to practice receptive anal intercourse was abysmally low. Zero per cent of such respondents had knowledge related to their anal cancer risk, and just half of them knew about HSV. Awareness certainly needs to be upped in people practicing receptive anal sex.

Read the Rest.

More safety data needed on lubricants used in anal sex


There is a growing realization that there is a significant issue of HIV acquisition through anal intercourse not only for men who have sex with men (MSM) who are clearly very visible HIV high risk group but increasingly for women who may be exposed to the virus through anal intercourse with their male partners. Also in recent studies, most people (men and women) who practice anal intercourse reported using some kind of a lubricant (such as gel, cream, or saliva among others).
So when the ongoing rectal microbicides research yields a safe and effective rectal microbicide towards later half of this decade, then rectal microbicide could be added to these lubricants as most people practicing anal intercourse are already comfortable with using lubricants, said Professor (Dr) Ian McGowan, Co-Chair of International Microbicides Conference (M2012) in Sydney, Australia; Professor, University of Pittsburgh School of Medicine, and co-principal investigator, Microbicide Trials Network (MTN).

Rectal microbicides are products that could take the form of gels or lubricants – being developed to reduce a person’s risk of HIV or other sexually transmitted infections (STIs) through anal receptive sex.

"What we have seen at this conference is that there is a growing evidence of MSM populations in African nations and HIV rates are alarmingly high in them" said Dr McGowan.
As per published data, not only MSM, there are number of women as well who reported to have anal sex. According to the data from a study in San Francisco, US, very high lubricant use was reported (89%) among those MSM who were practicing anal intercourse, said Dr Shauna Stahlman from Department of Epidemiology, University of California, Los Angeles (UCLA).

Read the Rest.


[If an item is not written by an IRMA member, it should not be construed that IRMA has taken a position on the article's content, whether in support or in opposition.]

Monday, March 19, 2012

Join IRMA and Partners for Dynamic Microbicides 2012 Advocates’ Pre-conference!

Please join us for this dynamic pre-conference….


Advocacy in a New Prevention Landscape:

BUILDING OUR KNOWLEDGE AND CAPACITY FOR EFFECTIVE ADVOCACY
AROUND HIV PREVENTION RESEARCH AND IMPLEMENTATION


Timing: Sunday 15 April 2012, 0830 to 1600
Venue: Sydney Convention & Exhibition Centre, Darling Harbour, Sydney

 
M2012 offers new opportunities and challenges to advocates across the world involved and/or interested in advocacy around microbicides and other HIV prevention research and rollout. We have new tools to consider in HIV prevention with the exciting results from PrEP and treatment as prevention trials - and yet confusing results from the early termination of the FEM-PrEP trial and the microbicide gel and tenofovir tablet arms of the VOICE study. What does this mean for communities and how does it affect the work we do as advocates?


The African Microbicides Advocacy Group, AVAC, the Global Campaign for Microbicides, IRMA (International Rectal Microbicides Advocates), the New HIV Vaccine & Microbicide Advocacy Society and local Australian partners ACON and AFAO will hold a day-long pre-conference workshop on Sunday, April 15. The M2012 Advocates' Pre-Conference Workshop will begin at 08:30 and conclude by 16:00, ensuring participants have ample time to get to the M2012 opening ceremony. The workshop will be held at the Sydney Convention & Exhibition Centre, and lunch will be provided.


The goal of the workshop is to equip new and experienced advocates, community representatives, trial staff and others with the tools needed to fully participate in the M2012 Conference by:

• Providing an overview of the field to contextualize the themes and issues presented at M2012;

• Connecting research and advocacy priorities and exploring common goals;

• Building capacity of advocates and trial staff to better engage with emerging issues in the field.


The pre-conference workshop will feature seasoned advocates and researchers from the HIV prevention research field who will provide participants with updates and previews to topics to be presented at the conference. An array of thematic discussion and skills-building sessions will be conducted including an update on key issues in the field, influencing relevant country policies and processes, prevention research literacy and ethics, and training on advocacy and campaign building.


Registration for this workshop is free for all interested participants but has limited space so registration will be offered on first-come first-served basis.


Registrations will be accepted through 23 March 2012 or until we have reached capacity.


To register – please fill this registration form at https://www.surveymonkey.com/s/39SPS5P. If you have any questions or having problems with the registration form, please write to M2012AdvocatesPrecon@gmail.com.


Organizers: AMAG, AVAC, GCM, IRMA and NHVMAS with Australian Partners ACON and AFAO


[If an item is not written by an IRMA member, it should not be construed that IRMA has taken a position on the article's content, whether in support or in opposition.]

Friday, January 13, 2012

Microbicides 2012 Conference Now Open for Registration!

M2012 Registration is Open!

"To share in the latest developments in HIV prevention through microbicides and other technologies, this is the conference to attend. The conference is the key event in the microbicides world, where cutting edge research will be presented by world experts, and you will have a chance to interact with people involved at every level of microbicides development "
-Professor John Kaldor, The Kirby Institute and Conference co-Chair

Come to Sydney in April for the 2012 International Microbicides Conference - 'From Discovery to Delivery', with state of the art plenary lectures on microbicides and other aspects of HIV prevention research, cross-disciplinary symposia, oral abstracts, and poster sessions.

M2012 will be a global forum for the presentation and discussion of the latest information on microbicides and oral pre-exposure prophylaxis for HIV prevention and their interface with other prevention strategies. There will be a strong emphasis on the role of community in both research and implementation of scientific findings. The conference is interdisciplinary, and will include basic science, pharmacokinetics, formulation and delivery, clinical research, public health, prevention science, and social and behavioural research.

WHY SHOULD YOU COME?
1. LEARN... From experts from around the world who will speak on key issues in HIV prevention technologies.
2. NETWORK... with a cross-disciplinary group of researchers, community representatives and policy makers, to support you in applying new approaches and perspectives in your work.
3. PARTICIPATE... in sessions that will range from state of the art lectures, to debates on hot topics in microbicides development.

Click here to learn more.


[If an item is not written by an IRMA member, it should not be construed that IRMA has taken a position on the article's content, whether in support or in opposition.]

Friday, November 11, 2011

Microbicides 2012 - Abstract and Scholarships Deadline EXTENDED TO FRIDAY 25 NOVEMBER 2011

IMPORTANT UPDATE:

Due to popular demand the deadline for the 2012 International Microbicides Conference abstract submissions and scholarship applications has been extended until Friday 25 November 2011!

Keep in mind that the date is actually November 24 for much of the world.



[If an item is not written by an IRMA member, it should not be construed that IRMA has taken a position on the article's content, whether in support or in opposition.]

Friday, July 22, 2011

SAVE THE DATE: M2012 is coming to Sydney, April 2012

The M2012 International Microbicides Conference is fast approaching. The conference will be held at Sydney Convention and Exhibition Centre, Sydney, Australia from Sunday 15 April to Wednesday 18 April 2012. It's time to make sure you mark these dates in your diary. 

Click here to learn more, including deadlines for early bird registration, abstract submissions and scholarship 

For more information or to register your interest please visit the website www.microbicides2012.org.

Also, please be aware that IRMA is working with other partners on a pre-conference - to be held Sunday April 15 before the full conference opening - and an Advocacy Corner. If you are interested, let us know.


[If an item is not written by an IRMA member, it should not be construed that IRMA has taken a position on the article's content, whether in support or in opposition.]
Related Posts Plugin for WordPress, Blogger...